<?xml version="1.0" encoding="UTF-8"?>
<p>Major clinical studies have been performed using evening primrose oil (from the seeds of 
 <italic>O. biennis</italic>), as a source of LA and GLA, in inflammatory diseases associated with immune system disorders, including atopic dermatitis, psoriasis, multiple sclerosis and rheumatoid arthritis. Standardized oils for the content in LA and ALA (for instance, Efamol is titred to contain 72% LA and 9% GLA) were usually used [
 <xref rid="B202-vaccines-08-00468" ref-type="bibr">202</xref>]. 
</p>
